Trial
NCT03040024
Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Emory University
Collaborators
—
Condition
Otolaryngeal Cancer
Intervention
Ketamine
Why stopped
Halted due to COVID 19; we believe we have adequate data for analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-07-08